Insider Transactions Reported by 13 Insiders of Aytu Biopharma, Inc

Symbol
AYTU on Nasdaq
Industry
Pharmaceutical Preparations
Location
Denver, CO

Insiders trading volume in the past year

Aytu Biopharma, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nantahala Capital Management, LLC 10%+ Owner $7.22M +$6M +491% Jun 6, 2025
Armistice Capital, Llc Director $5.02M Mar 20, 2021
Joshua R. Disbrow Chief Executive Officer, Director $487K +$119K +32.5% Oct 3, 2025
Gary Cantrell Director $307K Dec 21, 2022
Jarrett Disbrow Chief Business Officer $145K +$25K +20.9% Oct 3, 2025
Ryan J. Selhorn Chief Financial Officer $117K Oct 3, 2025
Greg Pyszczymuka Chief Commercial Officer $84.8K Oct 3, 2025
Vivian H. Liu Director $46.6K Oct 3, 2025
Abhinav Jain Director $45.8K Oct 3, 2025
Carl Dockery Director $36.2K Oct 3, 2025
John Donofrio Jr. Director $32.3K Oct 3, 2025
K. Oki Chief Financial Officer Aug 11, 2023
Christopher Brooke Chief Operating Officer Aug 11, 2023

Recent Insider Transactions by Companies or Individuals for Aytu Biopharma, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.